100 episodes

This is the podcast site for iForumRx.org - a community of ambulatory care pharmacy specialists and others interested in the last evidence regarding pharmacotherapeutics.

iForumRx.org University of Mississippi School of Pharmacy - Division of Pharmacy Professional Development

    • Medicine
    • 4.9 • 22 Ratings

This is the podcast site for iForumRx.org - a community of ambulatory care pharmacy specialists and others interested in the last evidence regarding pharmacotherapeutics.

    Closing the Loop for Children with Type 1 Diabetes

    Closing the Loop for Children with Type 1 Diabetes

    Insulin pumps and continuous glucose monitors (CGM) have changed the standard of care for managing Type 1 Diabetes. A closed-loop system (also described as an artificial pancreas or automated insulin delivery system) consists of a CGM, an insulin pump, and a control algorithm that automatically calculates basal insulin delivery based on real-time glucose levels. Closed-loop insulin pumps may offer an opportunity to improve glycemic management while reducing some of the associated stress. However, there are limited data evaluating the safety and efficacy of this technology in children less than 14 years old.
    Guest Authors:  Mary K Culp, PharmD and Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES
    Music by Good Talk

    • 20 min
    Is it Time to Add Colchicine to the CVD Cocktail?

    Is it Time to Add Colchicine to the CVD Cocktail?

    Systemic inflammation appears to be an important contributor to atherosclerotic cardiovascular disease but, to date, no medications have been approved that specifically target systemic inflammation. Could colchicine, an anti-inflammatory drug that has been used for decades, move from “perhaps-do” to a “must-do” standard of care for patients with coronary artery disease (CAD)? Data from two previous trials have demonstrated colchicine’s positive impact on cardiovascular outcomes. The LoDoCo2 study asks us, again, to consider colchicine for patients with CAD.
    Guest Authors:  Augustus (Rob) Hough, PharmD, BCCP and Taylor Huff, PharmD
    Music by Good Talk

    • 23 min
    Canagliflozin Comeback? New Data on the Risk of Amputation

    Canagliflozin Comeback? New Data on the Risk of Amputation

    Patients with diabetes are 10 times more likely to experience lower limb amputations than the general population and amputations have very significant morbidity, mortality, and financial implications. While common risk factors for amputation in patients with diabetes include poor glycemic control, diabetic peripheral neuropathy, or peripheral arterial disease, canagliflozin use was implicated in the CANVAS and CANVAS-R trials. However, the CANVAS Program trials were not specifically designed to evaluate the risk of lower-extremity amputations.  Clearly, we need more information about the magnitude of risk when canagliflozin is used widely in a general population and who is at most risk.
    Guest Authors:  Julie Dally, PharmD, BCPS, BCACP and Amanda Schartel, PharmD, BCACP
    Music by Good Talk

    • 17 min
    Using shared decision-making tools: Are they worth it?

    Using shared decision-making tools: Are they worth it?

    There’s no denying that shared decision making (SDM) is an effective communication approach for making patient-centered medical decisions across a variety of health conditions. However, while tools for SDM are often useful during patient visits with practitioners, studies have yielded mixed results with regard to patient outcomes.  A new study explores the impact of a SDM tool for anticoagulation selection in patients with atrial fibrillation compared to standard care.
    Guest Authors:  Ashley Meredith, PharmD, BCACP, BCPS, CDCES and Chandler Howell, PharmD
    Music by Good Talk

    • 19 min
    Less Might Be Better: Deprescribing Antihypertensive Medications in Older Adults

    Less Might Be Better: Deprescribing Antihypertensive Medications in Older Adults

    Health care professionals often don’t think twice about adding a new medication when a patient is not at goal. But we’re reluctant to stop a medication for a chronic condition when the patient appears to be stable and doing well.  Polypharmacy in older adults is a significant problem.  It’s costly and increases the likelihood of adverse effects. Several observational studies have suggested that lower blood pressure and multiple antihypertensive medications may be harmful in the elderly. Is it possible to discontinue medications without causing serious harm?
    Guest Authors: Keturah Weaver Pharm D, BCPS and Daniel Longyhore Pharm D, M.S., BCACP
    Music by Good Talk

    • 21 min
    Extracting Data on CBD: Effects on Opioid Use and Quality of Life

    Extracting Data on CBD: Effects on Opioid Use and Quality of Life

    Sales of cannabinoid-containing products continue to rise. In 2020 it became a billion-dollar industry. With the increased use and popularity of CBD products, every clinician needs to critically appraise the evidence to determine if CBD should play a role in pain management and help educate patients about the potential risks.
    Guest Author:  Alex R. Mills, PharmD, BCACP, AAHIVP
    Music by Good Talk

    • 18 min

Customer Reviews

4.9 out of 5
22 Ratings

22 Ratings

DavRAla2 ,

Concise and interesting

Appreciate the fact that always start with case study and try to relate study to actual practice.

RxLaura ,

Great!

A very informative and concise podcast to help keep updated on ambulatory care areas

Top Podcasts In Medicine

Listeners Also Subscribed To